Related Experiment Video
Updated: Jul 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
[Thrombinogenesis in chronic myeloproliferative syndromes]
Danuta Rość1, Elzbieta Kremplewska-Nalezyta, Grazyna Gadomska
1Uniwersytet Mikołaja Kpernika w Toruniu, Collegium Medicum w Bydgoszczy, Katedra Patofizjologii.
Unlabelled:
Haemostatic disturbances are important in clinical complications in patients with chronic myeloproliferative syndromes and sometimes the reason of death. Pathogenesis of thrombo-embolic disease during these states is not clear. The aim of study was the evaluation of the risk of thrombosis in patients with chronic myeloproliferative syndromes using very detailed test to measure the concentration of TAT (thrombin-antithrombin) complexes.
Material And Methods:
The study was performed in 73 patients: in 22 with chronic myeloid leucaemia (CML), in 25 with polycythemia vera (PV), in 21 with essential thrombocytemia (ET) and in 5 with myelofibrosis (MF). The control group consisted of 29 healthy volunteers. In the blood plasma of studied persons concentration of TAT complexes and antithrombin (AT) activity were detected.
Results:
We observed in patients, except MF, significant increase of TAT but diminished AT activity.
Conclusions:
Increased TAT complexes in chronic myeloproliferative syndromes is the evidence of significant thrombinogenesis. AT activity diminished in PV showes too high consumption of it with concomitant low synthesis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

